Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries

OBJECTIVE—Flow- (shear stress–)mediated outward remodeling of resistance arteries is involved in collateral growth during postischemic revascularization. As this remodeling is especially important during pregnancy, we hypothesized that estrogens may be involved. A surgical model eliciting a local in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2013-03, Vol.33 (3), p.605-611
Hauptverfasser: Tarhouni, K, Guihot, A L, Freidja, M L, Toutain, B, Henrion, B, Baufreton, C, Pinaud, F, Procaccio, V, Grimaud, L, Ayer, A, Loufrani, L, Lenfant, F, Arnal, J F, Henrion, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 611
container_issue 3
container_start_page 605
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 33
creator Tarhouni, K
Guihot, A L
Freidja, M L
Toutain, B
Henrion, B
Baufreton, C
Pinaud, F
Procaccio, V
Grimaud, L
Ayer, A
Loufrani, L
Lenfant, F
Arnal, J F
Henrion, D
description OBJECTIVE—Flow- (shear stress–)mediated outward remodeling of resistance arteries is involved in collateral growth during postischemic revascularization. As this remodeling is especially important during pregnancy, we hypothesized that estrogens may be involved. A surgical model eliciting a local increase in blood flow in 1 mesenteric resistance artery was used in 3-month-old ovariectomized female rats either treated with 17-β-estradiol (E2) or left untreated. METHODS AND RESULTS—After 14 days, arterial diameter was greater in high-flow arteries than in normal-flow vessels. An ovariectomy suppressed high-flow remodeling, while E2 restored it. High-flow remodeling was absent in mice lacking the estrogen receptor α but not estrogen receptor β. The kinetics of inflammatory marker expression, macrophage infiltration, oxidative stress, and metaloproteinases expression were not altered by the absence of E2 after 2 and 4 days, that is, during remodeling. Nevertheless, E2 was required for the increase in endothelial nitric oxide synthase expression and activation at day 4 when diameter expansion occurs. Finally, the impact of E2 on the endothelium appeared crucial for high-flow remodeling, as this E2 action was abrogated in mice lacking endothelial NOS, as well as in Tie2-Cre(+) ERα mice. CONCLUSION—We demonstrate the essential role of E2 and endothelial estrogen receptor α in flow-mediated remodeling of resistance arteries in vivo.
doi_str_mv 10.1161/ATVBAHA.112.300334
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03404023v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1288309661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3844-8554bf085105ef8002f8ac83d644ce20570f19db31fbbb9e713a7f7e485bdbe03</originalsourceid><addsrcrecordid>eNp9kU9u1DAUhyNERUvhAiyQl3SR8vwniWeZVlOmYiqkUWFrOfFzJ-CJBzth1B134CRchENwknqUYZas7Gd_v2_xfln2hsIlpSV9X99_uaoXdRrYJQfgXDzLzmjBRC5KXj5Pd6hmeVEKdpq9jPErAAjG4EV2yjiTkpbsLBs_4iNZeYfEWzKPQ_AP2Eeie0PmvfHDGl2n3fGHrLDF7eAD-fObdD25ct4bcuP87u_PX3doOj2gSdDGmxTsH_bWFcYuDrpvkdRhwNBhfJWdWO0ivj6c59nnm_n99SJffvpwe10v85ZLIXJZFKKxIAsKBVoJwKzUreSmFKJFBkUFls5Mw6ltmmaGFeW6shUKWTSmQeDn2cXkXWuntqHb6PCovO7Uol6q_RtwAQIY_0ET-25it8F_HzEOatPFFp3TPfoxKppWxmFWlnuUTWgbfIwB7dFNQe2rUYdq0sDUVE0KvT34x2aD5hj510UCygnYeZfWFL-5cYdBrVG7Yf0_8xPSk5xN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1288309661</pqid></control><display><type>article</type><title>Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Tarhouni, K ; Guihot, A L ; Freidja, M L ; Toutain, B ; Henrion, B ; Baufreton, C ; Pinaud, F ; Procaccio, V ; Grimaud, L ; Ayer, A ; Loufrani, L ; Lenfant, F ; Arnal, J F ; Henrion, D</creator><creatorcontrib>Tarhouni, K ; Guihot, A L ; Freidja, M L ; Toutain, B ; Henrion, B ; Baufreton, C ; Pinaud, F ; Procaccio, V ; Grimaud, L ; Ayer, A ; Loufrani, L ; Lenfant, F ; Arnal, J F ; Henrion, D</creatorcontrib><description>OBJECTIVE—Flow- (shear stress–)mediated outward remodeling of resistance arteries is involved in collateral growth during postischemic revascularization. As this remodeling is especially important during pregnancy, we hypothesized that estrogens may be involved. A surgical model eliciting a local increase in blood flow in 1 mesenteric resistance artery was used in 3-month-old ovariectomized female rats either treated with 17-β-estradiol (E2) or left untreated. METHODS AND RESULTS—After 14 days, arterial diameter was greater in high-flow arteries than in normal-flow vessels. An ovariectomy suppressed high-flow remodeling, while E2 restored it. High-flow remodeling was absent in mice lacking the estrogen receptor α but not estrogen receptor β. The kinetics of inflammatory marker expression, macrophage infiltration, oxidative stress, and metaloproteinases expression were not altered by the absence of E2 after 2 and 4 days, that is, during remodeling. Nevertheless, E2 was required for the increase in endothelial nitric oxide synthase expression and activation at day 4 when diameter expansion occurs. Finally, the impact of E2 on the endothelium appeared crucial for high-flow remodeling, as this E2 action was abrogated in mice lacking endothelial NOS, as well as in Tie2-Cre(+) ERα mice. CONCLUSION—We demonstrate the essential role of E2 and endothelial estrogen receptor α in flow-mediated remodeling of resistance arteries in vivo.</description><identifier>ISSN: 1079-5642</identifier><identifier>ISSN: 1524-4636</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.112.300334</identifier><identifier>PMID: 23288162</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Animals ; Blood Pressure - drug effects ; Caveolin 1 - metabolism ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Estradiol - administration &amp; dosage ; Estrogen Receptor alpha - agonists ; Estrogen Receptor alpha - deficiency ; Estrogen Receptor alpha - genetics ; Estrogen Receptor beta - deficiency ; Estrogen Receptor beta - genetics ; Estrogen Replacement Therapy ; Female ; Life Sciences ; Mesenteric Arteries - drug effects ; Mesenteric Arteries - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - deficiency ; Nitric Oxide Synthase Type III - genetics ; Ovariectomy ; Phosphorylation ; Rats ; Rats, Wistar ; Regional Blood Flow - drug effects ; Splanchnic Circulation - drug effects ; Time Factors ; Vascular Resistance - drug effects ; Vasodilation - drug effects</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2013-03, Vol.33 (3), p.605-611</ispartof><rights>2013 American Heart Association, Inc.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3844-8554bf085105ef8002f8ac83d644ce20570f19db31fbbb9e713a7f7e485bdbe03</citedby><cites>FETCH-LOGICAL-c3844-8554bf085105ef8002f8ac83d644ce20570f19db31fbbb9e713a7f7e485bdbe03</cites><orcidid>0000-0003-3397-2335 ; 0000-0002-7571-4062</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23288162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-angers.hal.science/hal-03404023$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Tarhouni, K</creatorcontrib><creatorcontrib>Guihot, A L</creatorcontrib><creatorcontrib>Freidja, M L</creatorcontrib><creatorcontrib>Toutain, B</creatorcontrib><creatorcontrib>Henrion, B</creatorcontrib><creatorcontrib>Baufreton, C</creatorcontrib><creatorcontrib>Pinaud, F</creatorcontrib><creatorcontrib>Procaccio, V</creatorcontrib><creatorcontrib>Grimaud, L</creatorcontrib><creatorcontrib>Ayer, A</creatorcontrib><creatorcontrib>Loufrani, L</creatorcontrib><creatorcontrib>Lenfant, F</creatorcontrib><creatorcontrib>Arnal, J F</creatorcontrib><creatorcontrib>Henrion, D</creatorcontrib><title>Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Flow- (shear stress–)mediated outward remodeling of resistance arteries is involved in collateral growth during postischemic revascularization. As this remodeling is especially important during pregnancy, we hypothesized that estrogens may be involved. A surgical model eliciting a local increase in blood flow in 1 mesenteric resistance artery was used in 3-month-old ovariectomized female rats either treated with 17-β-estradiol (E2) or left untreated. METHODS AND RESULTS—After 14 days, arterial diameter was greater in high-flow arteries than in normal-flow vessels. An ovariectomy suppressed high-flow remodeling, while E2 restored it. High-flow remodeling was absent in mice lacking the estrogen receptor α but not estrogen receptor β. The kinetics of inflammatory marker expression, macrophage infiltration, oxidative stress, and metaloproteinases expression were not altered by the absence of E2 after 2 and 4 days, that is, during remodeling. Nevertheless, E2 was required for the increase in endothelial nitric oxide synthase expression and activation at day 4 when diameter expansion occurs. Finally, the impact of E2 on the endothelium appeared crucial for high-flow remodeling, as this E2 action was abrogated in mice lacking endothelial NOS, as well as in Tie2-Cre(+) ERα mice. CONCLUSION—We demonstrate the essential role of E2 and endothelial estrogen receptor α in flow-mediated remodeling of resistance arteries in vivo.</description><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Caveolin 1 - metabolism</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Estradiol - administration &amp; dosage</subject><subject>Estrogen Receptor alpha - agonists</subject><subject>Estrogen Receptor alpha - deficiency</subject><subject>Estrogen Receptor alpha - genetics</subject><subject>Estrogen Receptor beta - deficiency</subject><subject>Estrogen Receptor beta - genetics</subject><subject>Estrogen Replacement Therapy</subject><subject>Female</subject><subject>Life Sciences</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Mesenteric Arteries - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - deficiency</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Ovariectomy</subject><subject>Phosphorylation</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Regional Blood Flow - drug effects</subject><subject>Splanchnic Circulation - drug effects</subject><subject>Time Factors</subject><subject>Vascular Resistance - drug effects</subject><subject>Vasodilation - drug effects</subject><issn>1079-5642</issn><issn>1524-4636</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9u1DAUhyNERUvhAiyQl3SR8vwniWeZVlOmYiqkUWFrOfFzJ-CJBzth1B134CRchENwknqUYZas7Gd_v2_xfln2hsIlpSV9X99_uaoXdRrYJQfgXDzLzmjBRC5KXj5Pd6hmeVEKdpq9jPErAAjG4EV2yjiTkpbsLBs_4iNZeYfEWzKPQ_AP2Eeie0PmvfHDGl2n3fGHrLDF7eAD-fObdD25ct4bcuP87u_PX3doOj2gSdDGmxTsH_bWFcYuDrpvkdRhwNBhfJWdWO0ivj6c59nnm_n99SJffvpwe10v85ZLIXJZFKKxIAsKBVoJwKzUreSmFKJFBkUFls5Mw6ltmmaGFeW6shUKWTSmQeDn2cXkXWuntqHb6PCovO7Uol6q_RtwAQIY_0ET-25it8F_HzEOatPFFp3TPfoxKppWxmFWlnuUTWgbfIwB7dFNQe2rUYdq0sDUVE0KvT34x2aD5hj510UCygnYeZfWFL-5cYdBrVG7Yf0_8xPSk5xN</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Tarhouni, K</creator><creator>Guihot, A L</creator><creator>Freidja, M L</creator><creator>Toutain, B</creator><creator>Henrion, B</creator><creator>Baufreton, C</creator><creator>Pinaud, F</creator><creator>Procaccio, V</creator><creator>Grimaud, L</creator><creator>Ayer, A</creator><creator>Loufrani, L</creator><creator>Lenfant, F</creator><creator>Arnal, J F</creator><creator>Henrion, D</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-3397-2335</orcidid><orcidid>https://orcid.org/0000-0002-7571-4062</orcidid></search><sort><creationdate>201303</creationdate><title>Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries</title><author>Tarhouni, K ; Guihot, A L ; Freidja, M L ; Toutain, B ; Henrion, B ; Baufreton, C ; Pinaud, F ; Procaccio, V ; Grimaud, L ; Ayer, A ; Loufrani, L ; Lenfant, F ; Arnal, J F ; Henrion, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3844-8554bf085105ef8002f8ac83d644ce20570f19db31fbbb9e713a7f7e485bdbe03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Caveolin 1 - metabolism</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Estradiol - administration &amp; dosage</topic><topic>Estrogen Receptor alpha - agonists</topic><topic>Estrogen Receptor alpha - deficiency</topic><topic>Estrogen Receptor alpha - genetics</topic><topic>Estrogen Receptor beta - deficiency</topic><topic>Estrogen Receptor beta - genetics</topic><topic>Estrogen Replacement Therapy</topic><topic>Female</topic><topic>Life Sciences</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Mesenteric Arteries - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - deficiency</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Ovariectomy</topic><topic>Phosphorylation</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Regional Blood Flow - drug effects</topic><topic>Splanchnic Circulation - drug effects</topic><topic>Time Factors</topic><topic>Vascular Resistance - drug effects</topic><topic>Vasodilation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tarhouni, K</creatorcontrib><creatorcontrib>Guihot, A L</creatorcontrib><creatorcontrib>Freidja, M L</creatorcontrib><creatorcontrib>Toutain, B</creatorcontrib><creatorcontrib>Henrion, B</creatorcontrib><creatorcontrib>Baufreton, C</creatorcontrib><creatorcontrib>Pinaud, F</creatorcontrib><creatorcontrib>Procaccio, V</creatorcontrib><creatorcontrib>Grimaud, L</creatorcontrib><creatorcontrib>Ayer, A</creatorcontrib><creatorcontrib>Loufrani, L</creatorcontrib><creatorcontrib>Lenfant, F</creatorcontrib><creatorcontrib>Arnal, J F</creatorcontrib><creatorcontrib>Henrion, D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tarhouni, K</au><au>Guihot, A L</au><au>Freidja, M L</au><au>Toutain, B</au><au>Henrion, B</au><au>Baufreton, C</au><au>Pinaud, F</au><au>Procaccio, V</au><au>Grimaud, L</au><au>Ayer, A</au><au>Loufrani, L</au><au>Lenfant, F</au><au>Arnal, J F</au><au>Henrion, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2013-03</date><risdate>2013</risdate><volume>33</volume><issue>3</issue><spage>605</spage><epage>611</epage><pages>605-611</pages><issn>1079-5642</issn><issn>1524-4636</issn><eissn>1524-4636</eissn><abstract>OBJECTIVE—Flow- (shear stress–)mediated outward remodeling of resistance arteries is involved in collateral growth during postischemic revascularization. As this remodeling is especially important during pregnancy, we hypothesized that estrogens may be involved. A surgical model eliciting a local increase in blood flow in 1 mesenteric resistance artery was used in 3-month-old ovariectomized female rats either treated with 17-β-estradiol (E2) or left untreated. METHODS AND RESULTS—After 14 days, arterial diameter was greater in high-flow arteries than in normal-flow vessels. An ovariectomy suppressed high-flow remodeling, while E2 restored it. High-flow remodeling was absent in mice lacking the estrogen receptor α but not estrogen receptor β. The kinetics of inflammatory marker expression, macrophage infiltration, oxidative stress, and metaloproteinases expression were not altered by the absence of E2 after 2 and 4 days, that is, during remodeling. Nevertheless, E2 was required for the increase in endothelial nitric oxide synthase expression and activation at day 4 when diameter expansion occurs. Finally, the impact of E2 on the endothelium appeared crucial for high-flow remodeling, as this E2 action was abrogated in mice lacking endothelial NOS, as well as in Tie2-Cre(+) ERα mice. CONCLUSION—We demonstrate the essential role of E2 and endothelial estrogen receptor α in flow-mediated remodeling of resistance arteries in vivo.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>23288162</pmid><doi>10.1161/ATVBAHA.112.300334</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3397-2335</orcidid><orcidid>https://orcid.org/0000-0002-7571-4062</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2013-03, Vol.33 (3), p.605-611
issn 1079-5642
1524-4636
1524-4636
language eng
recordid cdi_hal_primary_oai_HAL_hal_03404023v1
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Animals
Blood Pressure - drug effects
Caveolin 1 - metabolism
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Estradiol - administration & dosage
Estrogen Receptor alpha - agonists
Estrogen Receptor alpha - deficiency
Estrogen Receptor alpha - genetics
Estrogen Receptor beta - deficiency
Estrogen Receptor beta - genetics
Estrogen Replacement Therapy
Female
Life Sciences
Mesenteric Arteries - drug effects
Mesenteric Arteries - metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
Nitric Oxide - metabolism
Nitric Oxide Synthase Type III - deficiency
Nitric Oxide Synthase Type III - genetics
Ovariectomy
Phosphorylation
Rats
Rats, Wistar
Regional Blood Flow - drug effects
Splanchnic Circulation - drug effects
Time Factors
Vascular Resistance - drug effects
Vasodilation - drug effects
title Key Role of Estrogens and Endothelial Estrogen Receptor α in Blood Flow–Mediated Remodeling of Resistance Arteries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Key%20Role%20of%20Estrogens%20and%20Endothelial%20Estrogen%20Receptor%20%CE%B1%20in%20Blood%20Flow%E2%80%93Mediated%20Remodeling%20of%20Resistance%20Arteries&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Tarhouni,%20K&rft.date=2013-03&rft.volume=33&rft.issue=3&rft.spage=605&rft.epage=611&rft.pages=605-611&rft.issn=1079-5642&rft.eissn=1524-4636&rft_id=info:doi/10.1161/ATVBAHA.112.300334&rft_dat=%3Cproquest_hal_p%3E1288309661%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1288309661&rft_id=info:pmid/23288162&rfr_iscdi=true